NF‐κB pathway is generally activated in PCNSL, and gene alterations that lead to its deregulation, such as activating mutations of CARD11 and MYD88, are often involved 35, 36, 37, 38. This evidence concerns the gene CARD11 and primary central nervous system lymphoma.